{"entity":{"type":"insider","cik":"0001705278","url":"/insider/0001705278","json_url":"/insider/0001705278.json","name":"TURKEL CATHERINE C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2017-05-11","last":"2024-08-13","span_basis":"filed_date"},"name_variants":[{"name":"TURKEL CATHERINE C.","source":"filing","n_filings":6,"first_seen":"2017-05-11","last_seen":"2024-08-13"}],"transactions":[{"id":2524413,"accession":"0001855763-24-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001855763-24-000013","line_url":"/filing/0001855763-24-000013#line-1","is_derivative":false,"issuer_cik":"0001348362","issuer_name":"Lexaria Bioscience Corp.","issuer_ticker":"LEXX","issuer_name_source":null,"issuer_url":"/issuer/0001348362","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Director","officer_title":null,"security_title":"common shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":3.13,"price_display":"3.13","price_state":"stated","total_value":5008.0,"total_display":"5,008.00","shares_owned_after":3100.0,"shares_owned_after_display":"3,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":8212581,"accession":"0001855763-23-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001855763-23-000001","line_url":"/filing/0001855763-23-000001#line-1","is_derivative":false,"issuer_cik":"0001348362","issuer_name":"Lexaria Bioscience Corp.","issuer_ticker":"LEXX","issuer_name_source":null,"issuer_url":"/issuer/0001348362","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.8446,"price_display":"2.84","price_state":"stated","total_value":4266.9,"total_display":"4,266.90","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-27","scope":"insider"},{"id":8630252,"accession":"0001562180-19-003055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-003055","line_url":"/filing/0001562180-19-003055#line-2","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1914.0,"shares_display":"1,914","price_per_share":1.9114,"price_display":"1.91","price_state":"stated","total_value":3658.4196,"total_display":"3,658.42","shares_owned_after":88662.0,"shares_owned_after_display":"88,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider"},{"id":8630249,"accession":"0001562180-19-003055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-003055","line_url":"/filing/0001562180-19-003055#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7623.0,"shares_display":"7,623","price_per_share":1.9616,"price_display":"1.96","price_state":"stated","total_value":14953.2768,"total_display":"14,953.28","shares_owned_after":90576.0,"shares_owned_after_display":"90,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":6344066,"accession":"0000899243-18-024470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-024470","line_url":"/filing/0000899243-18-024470#line-2","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16632.0,"shares_display":"16,632","price_per_share":5.019,"price_display":"5.02","price_state":"stated","total_value":83476.008,"total_display":"83,476.01","shares_owned_after":78199.0,"shares_owned_after_display":"78,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-13","scope":"insider"},{"id":6344063,"accession":"0000899243-18-024470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-024470","line_url":"/filing/0000899243-18-024470#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17048.0,"shares_display":"17,048","price_per_share":4.556,"price_display":"4.56","price_state":"stated","total_value":77670.688,"total_display":"77,670.69","shares_owned_after":61567.0,"shares_owned_after_display":"61,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-11","filed_date":"2018-09-13","scope":"insider"},{"id":6812462,"accession":"0000899243-18-024043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-024043","line_url":"/filing/0000899243-18-024043#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Officer (President)","officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":805.0,"shares_display":"805","price_per_share":3.966,"price_display":"3.97","price_state":"stated","total_value":3192.63,"total_display":"3,192.63","shares_owned_after":805.0,"shares_owned_after_display":"805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-07","scope":"insider"},{"id":4481632,"accession":"0000899243-17-012934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-012934","line_url":"/filing/0000899243-17-012934#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001705278","owner_name":"TURKEL CATHERINE C.","owner_url":"/insider/0001705278","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11111.0,"shares_display":"11,111","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":110998.89,"total_display":"110,998.89","shares_owned_after":24519.0,"shares_owned_after_display":"24,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348362","name":"Lexaria Bioscience Corp.","url":"/issuer/0001348362","role":"Director","n_filings":2,"first_seen":"2023-02-27","last_seen":"2024-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Novus Therapeutics, Inc.","url":"/issuer/0001404281","role":"Officer (President)","n_filings":4,"first_seen":"2017-05-11","last_seen":"2019-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001705278","retrieved_at":"2026-08-21T03:05:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}